BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8786975)

  • 1. Characterization of LLC-PK1 kidney epithelial cells as an in vitro model for studying renal tubular reabsorption of protein drugs.
    Takakura Y; Morita T; Fujikawa M; Hayashi M; Sezaki H; Hashida M; Borchardt RT
    Pharm Res; 1995 Dec; 12(12):1968-72. PubMed ID: 8786975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Na superset+/H superset+ exchange decreases albumin-induced NF-kappaB activation in renal proximal tubular cell lines (OK and LLC-PK1 cells).
    Drumm K; Gassner B; Silbernagl S; Gekle M
    Eur J Med Res; 2001 Oct; 6(10):422-32. PubMed ID: 11698229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human red blood cell hemolysate is a potent mitogen for renal tubular epithelial cells.
    Anderson RJ; Ray CJ; Burke TJ
    Ren Fail; 2000 May; 22(3):267-81. PubMed ID: 10843238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incubation of porcine high-density lipoprotein with the apical surface of LLC-PK1 renal tubular cells sustains the properties of orientated monolayers.
    Streather CP; Owen JS; Hendry BM; Scoble JE
    Nephrol Dial Transplant; 1996 Mar; 11(3):431-7. PubMed ID: 8671811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular uptake properties of oligonucleotides in LLC-PK1 renal epithelial cells.
    Takakura Y; Oka Y; Hashida M
    Antisense Nucleic Acid Drug Dev; 1998 Feb; 8(1):67-73. PubMed ID: 9512098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cardiac glycosides on sodium pump expression and function in LLC-PK1 and MDCK cells.
    Liu J; Periyasamy SM; Gunning W; Fedorova OV; Bagrov AY; Malhotra D; Xie Z; Shapiro JI
    Kidney Int; 2002 Dec; 62(6):2118-25. PubMed ID: 12427136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of erythropoietin against radiocontrast-induced renal tubular epithelial cell injury.
    Kolyada AY; Liangos O; Madias NE; Jaber BL
    Am J Nephrol; 2008; 28(2):203-9. PubMed ID: 17960058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular cGMP inhibits transepithelial sodium transport by LLC-PK1 renal tubular cells.
    Chevalier RL; Fang GD; Garmey M
    Am J Physiol; 1996 Feb; 270(2 Pt 2):F283-8. PubMed ID: 8779888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytofluorimetric analysis of a renal tubular cell line and its resistant counterpart.
    Rosati A; Decorti G; Klugmann FB; Candussio L; Granzotto M; Melato M; Giraldi T
    Anticancer Res; 2000; 20(5B):3403-10. PubMed ID: 11131640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporine A-induced toxicity in two renal cell culture models (LLC-PK1 and MDCK).
    Rezzani R; Angoscini P; Borsani E; Rodella L; Bianchi R
    Histochem J; 2002; 34(1-2):27-33. PubMed ID: 12365797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential autocrine and paracrine mechanisms of recovery from mechanical injury of renal tubular epithelial cells.
    Anderson RJ; Ray CJ
    Am J Physiol; 1998 Mar; 274(3):F463-72. PubMed ID: 9530262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcellular transport of creatinine in renal tubular epithelial cell line LLC-PK1.
    Urakami Y; Kimura N; Okuda M; Masuda S; Katsura T; Inui K
    Drug Metab Pharmacokinet; 2005 Jun; 20(3):200-5. PubMed ID: 15988122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro-in vivo extrapolation method to predict human renal clearance of drugs.
    Kunze A; Huwyler J; Poller B; Gutmann H; Camenisch G
    J Pharm Sci; 2014 Mar; 103(3):994-1001. PubMed ID: 24549735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transport of quinolone antibacterial drugs by human P-glycoprotein expressed in a kidney epithelial cell line, LLC-PK1.
    Ito T; Yano I; Tanaka K; Inui KI
    J Pharmacol Exp Ther; 1997 Aug; 282(2):955-60. PubMed ID: 9262363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Danofloxacin on Reactive Oxygen Species Production, Lipid Peroxidation and Antioxidant Enzyme Activities in Kidney Tubular Epithelial Cell Line, LLC-PK1.
    Yu CH; Liu ZY; Sun LS; Li YJ; Zhang DS; Pan RT; Sun ZL
    Basic Clin Pharmacol Toxicol; 2013 Dec; 113(6):377-84. PubMed ID: 23855763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Handling of doxorubicin by the LLC-PK1 kidney epithelial cell line.
    Decorti G; Peloso I; Favarin D; Klugmann FB; Candussio L; Crivellato E; Mallardi F; Baldini L
    J Pharmacol Exp Ther; 1998 Jul; 286(1):525-30. PubMed ID: 9655898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uptake of doxorubicin by cultured kidney epithelial cells LLC-PK1.
    Sasaya M; Wada I; Shida M; Sato M; Hatakeyama Y; Saitoh H; Takada M
    Biol Pharm Bull; 1998 May; 21(5):527-9. PubMed ID: 9635513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Na(+)-dependent uptake of 1,5-anhydro-D-glucitol via the transport systems for D-glucose and D-mannose in the kidney epithelial cell line, LLC-PK1.
    Saito H; Ohtomo T; Inui K
    Nihon Jinzo Gakkai Shi; 1996 Oct; 38(10):435-40. PubMed ID: 8940824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Free radical scavengers, catalase and superoxide dismutase provide protection from oxalate-associated injury to LLC-PK1 and MDCK cells.
    Thamilselvan S; Byer KJ; Hackett RL; Khan SR
    J Urol; 2000 Jul; 164(1):224-9. PubMed ID: 10840464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of proliferation and functional differentiation of LLC-PK1 cells on porous polymer membranes for the development of a bioartificial renal tubule device.
    Sato Y; Terashima M; Kagiwada N; Tun T; Inagaki M; Kakuta T; Saito A
    Tissue Eng; 2005; 11(9-10):1506-15. PubMed ID: 16259605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.